Psychotropic dose equivalence in Japan
Table 1 Dose equivalence of antipsychotics†
Aripiprazole |
4 |
Blonanserin |
4 |
Bromperidol |
2 |
Carpipramine‡ |
100 |
Chlorpromazine |
100 |
Clocapramine |
40 |
Clotiapine‡ |
40 |
Clozapine |
50 |
Fluphenazine |
2 |
Haloperidol |
2 |
Levomepromazine |
100 |
Moperone |
12.5 |
Mosapramine |
33 |
Nemonapride |
4.5 |
Olanzapine |
2.5 |
Oxypertine |
80 |
Paliperidone |
1.5 |
Perazine‡ |
100 |
Perospirone |
8 |
Perphenazine |
10 |
Pimozide |
4 |
Pipamperone |
200 |
Prochlorperazine |
15 |
Propericiazine |
20 |
Quetiapine |
66 |
Reserpine |
0.15 |
risperidone |
1 |
Spiperone |
1 |
Sulpiride |
200 |
Sultopride |
200 |
Thioridazine‡ |
100 |
Tiapride |
100 |
Timiperone |
1.3 |
Thiothixene‡ |
3.3 |
Trifluoperazine‡ |
5 |
Zotepine |
66 |
†Adapted from the previous publications.5–15
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
‡No longer available in Japan.
Return to top
Table 2 Dose equivalence of short-acting injectable antipsychotics
Based on oral chlorpromazine 100 mg (p.o.)
Injectable antipsychotics |
Equivalent dose of 100 mg chlorpromazine (p.o.) (mg) |
Chlorpromazine (p.o.) |
100 |
Haloperidol (i.m./i.v.) |
1 |
Chlorpromazine (i.m.) |
33 |
Levomepromazine (i.m.) |
25 |
Sulpiride (i.m.) |
50 |
Perphenazine (i.m.) |
2 |
Prochlorperazine (i.m.) |
2.14 |
Timiperone (i.m./i.v.) |
0.19 |
Olanzapine (i.m.) |
2.25 |
Based on the same oral agent (p.o.)
Injectable antipsychotics |
(mg) |
Equivalent dose of oral
administration |
(mg) |
Haloperidol (i.m./i.v.) |
5 |
Haloperidol (p.o.) |
10 |
Chlorpromazine (i.m.) |
50 |
Chlorpromazine (p.o.) |
150 |
Levomepromazine (i.m.) |
25 |
Levomepromazine (p.o.) |
100 |
Sulpiride (i.m.) |
50 |
Sulpiride (p.o.) |
200 |
Perphenazine (i.m.) |
2 |
Perphenazine (p.o.) |
10 |
Prochlorperazine (i.m.) |
5 |
Prochlorperazine (p.o.) |
35 |
Timiperone (i.m./i.v.) |
4 |
Timiperone (p.o.) |
28 |
Olanzapine (i.m.) |
9 |
Olanzapine (p.o.) |
10 |
Adapted from the previous publication28 and the booklet ‘2014 Year Edition of Drug Directory for Neuropsychiatric Diseases’ (not for sale) designed by the Mitsubishi Tanabe Pharma Corporation (Osaka) and the Yoshitomiyakuhin Corporation (Osaka), published by the Seiwa Shoten Publishers Inc. (Tokyo) in 2014.
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
i.m., intramuscular injection; i.v., intravenous injection; p.o., oral administration (per os).
Return to top
Table 3 Dose equivalence of long-acting injectable antipsychotics†
Oral antipsychotics |
Long-acting antipsychotics |
Chlorpromazine |
100 mg/day |
|
|
Haloperidol |
2 mg/day |
HP-D |
30 mg/4 weeks |
Fluphenazine |
2 mg/day |
FE‡ |
7.5 mg/2 weeks |
|
|
FD |
15 mg/4 weeks |
Risperidone |
1 mg/day |
RLAI |
10 mg/2 weeks |
Paliperidone |
1.5 mg/day |
PAL-P |
18.75 mg/4 weeks |
†Adapted from the previous publications13,29–31 and the booklet ‘2014 Year Edition of Drug Directory for Neuropsychiatric Diseases’ (not for sale) designed by the Mitsubishi Tanabe Pharma Corporation (Osaka) and the Yoshitomiyakuhin Corporation (Osaka), published by the Seiwa Shoten Publishers Inc. (Tokyo) in 2014.
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
‡No longer available in Japan.
FD, fluphenazine decanoate; FE, fluphenazine enanthate; HP-D, haloperidol decanoate; PAL-P, paliperidone palmitate; RLAI, risperidone long-acting injection.
Return to top
Table 4 Dose equivalence of antiparkinsonian drugs†
Amantadine |
100 |
Benztropine‡ |
1 |
Biperiden |
2 |
Diphenhydramine |
30 |
Hydroxyzine |
65 |
Mazaticol |
8 |
Metixene‡ |
10 |
Piroheptine |
4 |
Profenamine |
100 |
Promethazine |
50 |
Trihexyphenidyl |
4 |
†Adapted from the previous publications.32,33
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
‡No longer available in Japan.
Return to top
Table 5 Dose equivalence of antidepressants†
Amitriptyline |
150 |
Amoxapine |
150 |
Clomipramine |
120 |
Desipramine‡ |
150 |
Dosulepin |
150 |
Duloxetine |
30 |
Escitalopram |
20 |
Fluvoxamine |
150 |
Imipramine |
150 |
Lofepramine |
150 |
Maprotiline |
150 |
Mianserin |
60 |
Milnacipran |
100 |
Mirtazapine |
30 |
Nortriptyline |
75 |
Paroxetine |
40 |
Paroxetine CR |
50 |
Safrazine‡ |
30 |
Sertraline |
100 |
Setiptiline |
6 |
Sulpiride |
300 |
Trazodone |
300 |
Trimipramine |
150 |
†Adapted from the previous publications13,38–40 and the booklet ‘2014 Year Edition of Drug Directory for Neuropsychiatric Diseases’ (not for sale) designed by the Mitsubishi Tanabe Pharma Corporation (Osaka) and the Yoshitomiyakuhin Corporation (Osaka), published by the Seiwa Shoten Publishers Inc. (Tokyo) in 2014.
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
‡No longer available in Japan.
Return to top
Table 6 Dose equivalence of anxiolytics, sedatives and hypnotics†
Alprazolam |
0.8 |
Bromazepam |
2.5 |
Chlordiazepoxide |
10 |
Clobazam |
10 |
Clonazepam |
0.25 |
Clorazepate |
7.5 |
Clotiazepam |
10 |
Cloxazolam |
1.5 |
Diazepam |
5 |
Etizolam |
1.5 |
Fludiazepam |
0.5 |
Flutazolam |
15 |
Flutoprazepam |
1.67 |
Loflazepate |
1.67 |
Lorazepam |
1.2 |
Medazepam |
10 |
Mexazolam |
1.67 |
Oxazepam‡ |
15 |
Oxazolam |
20 |
Prazepam‡ |
12.5 |
Tandospirone |
25 |
Tofisopam |
125 |
Amobarbital |
50 |
Barbital |
75 |
Bromvalerylurea |
500 |
Brotizolam |
0.25 |
Butoctamide‡ |
500 |
Chloral hydrate |
250 |
Estazolam |
2 |
Eszopiclone |
2.5 |
Flunitrazepam |
1 |
Flurazepam |
15 |
Haloxazolam |
5 |
Lormetazepam |
1 |
Nimetazepam |
5 |
Nitrazepam |
5 |
Passiflora extract |
100 |
Pentobarbital |
50 |
Phenobarbital |
15 |
Quazepam |
15 |
Rilmazafone |
2 |
Secobarbital |
50 |
Triazolam |
0.25 |
Zolpidem |
10 |
Zopiclone |
7.5 |
†Adapted from the previous publications.13,43–45
Reproduced with permission. ©Ataru Inagaki & Toshiya Inada.
‡No longer available in Japan.
Return to top